India on Tuesday got its second Covid-19 vaccine for children aged above two years as Bharat Biotech's Covaxin was approved. The details of the rollout of the vaccine is yet to be discovered.
Even though Zydus Cadila's ZyCoV-D had previously received approval for children of 12 years and above, the first vaccine to cater to younger is yet to be publicly available, Bharat Biotech's Covaxin will become the first vaccine to be used for children immediately.
The homegrown vaccine is yet to secure approval from the World Health Organisation, with officials insisting that a decision would be coming shortly. According to reports, India's Subject Expert Committee on COVID-19 has granted emergency usage approval to the jab.
As per reports, a recent trial showed that the safety and immunogenicity of Covaxin are almost the same in children, as adults above 18 years of age. The trials were done in three age brackets. The first group examined was between 12 -18 years, the second group was between 6- 12 years and the third age group was between 2-6 years.